SATB1 and glioblastoma: To exclude false-positive results due to off-target effects and to allow the establishment of gene-dose effects, two siRNAs validated previously for specific SATB1 knockdown to different degrees were employed and compared to untreated as well as to negative control transfected cells (siRNA targeting the luciferase gene which is not expressed in glioblastoma cells).